We evaluated this trade-off by comparing the ability for calling the SF3B1 K700E hotspot mutation, which is characteristic of MDS and can thus be considered true somatic, versus the overall number of false-positive calls in the normal panel as discussed in the previous section. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.